Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice

Cancer Research

Volumn 67, Issue 9, 2007, Pages 4399-4407

  Ganesh, Shanthi ^a   Edick, Melissa Gonzalez ^a   Idamakanti, Neeraja ^a   Abramova, Marina ^a   VanRoey, Melinda ^a   Robinson, Michael ^a   Yun, Chae Ok ^b   Jooss, Karin ^a  

^a CELL GENESYS INC   (United States)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

RELAXIN; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; FIBER; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL; TUMOR CELL; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CELL LINE, TUMOR; COLLAGEN; FEMALE; GENETIC VECTORS; HUMANS; MALE; MICE; NEOPLASM METASTASIS; ONCOLYTIC VIROTHERAPY; PROSTATIC NEOPLASMS; RELAXIN; VIRUS REPLICATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 34249316871     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-4260     Document Type: Article

References (41)

1. Parato KA, Senger D, Bell JC, et al. Recent progress in the battle between oncolytic viruses and tumors. Nature 2005;5:965-76.
2. Okegawa T, Li Y, Hsieh JT, et al. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res 2000;60:5031-6.
3. Li Y, Pong RC, Hsieh JT, et al. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res 1999;59:325-30.
4. Bergelson JM, Cunningham JA, Hong JS, et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997;275:1320-3.
5. Miller CR, Buchsbaum DJ, Mayo MS, et al. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res 1998;58:5738-48.
6. Reddy PS, Ganesh S, Yu DC. Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses. Clin Cancer Res 2006;12:2869-78.
7. Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003;9:1408-12.
8. Nilsson M, Ljungberg J, Richter J, et al. Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells. J Gene Med 2004;6:631-41.
9. Harrison D, Sauthoff H, Hay JG, et al. Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved-deletion of the viral E1b-19-kD gene increases the viral oncolytic effect. Hum Gene Ther 2001;12:1323-32.
10. Sauthoff H, Hu J, Hay JG, et al. Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points. Hum Gene Ther 2003;14:425-33.
11. Kuriyama N, Kuriyama H, Julin CM, Lamborn K, Israel MA. Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy. Hum Gene Ther 2000;11:2219-30.
12. Kuriyama N, Kuriyama H, Julin CM, Lamborn K, Israel MA. Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy. Cancer Res 2000;61:1805-9.
13. David Sherwood O. Relaxin's physiological roles and other diverse actions. Endocr Rev 2004;25:205-34.
14. Baccari MC, Calamai F. Relaxin: new functions for an old peptide. Curr Protein Pept Sci 2004;5:9-18.
15. Silvertown JD, Alastair J, Summerlee S, Klonisch T. Relaxin-like peptide in cancer. Int J Cancer 2003;107:513-9.
16. Brown E, McKee T, Jain RK, et al. Dynamic imaging and its modulation in tumors in vivo using second-harmonic generation. Nat Med 2003;9:796-800.
17. Unemori E, Amento E. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem 1990;265:10681-5.
18. Binder C, Hagemann Th, Husen B, Schulz M, Einspanier A. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metailoproteases. Mol Hum Reprod 2002;8:789-96.
19. Binder C, Simon A, Einspanier A, et al. Elevated concentrations of serum relaxin are associated with metastatic disease in breast cancer patients. Breast Cancer Res Treat 2004;87:157-66.
20. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev 2002;2:161-6.
21. Kim JH, Lee YS, Kim H, Huang JH, Yoon AR, Yun CO. Relaxin expression from tumor targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy. J Natl Cancer Inst 2006;98:1482-93.
22. Ramesh N, Ge Y, Ennist DL, et al. CG0070, a conditionally replicating GM-CSF-armed oncolytic adenovirus for the treatment of bladder cancer. Clin Cancer Res 2006;12:305-13.
23. Bristol A, Zhu M, Ji H, et al. In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF. Mol Ther 2003;7:755-64.
24. Gorziglia MI, Lapcevich C, Roy S, et al. Generation of an adenovirus vector lacking E1, E2a, E3 and all of E4 except open reading frame 3. J Virol 1999;73:6048-55.
25. Mittereder N, Marck KL, Trapnell BC. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 1996;70:7498-509.
26. Rubio N, Villacampa MM, Hilali El, Blanco J. Metastatic burden in nude mice organs measured using prostate tumor PC-3 cells expressing the luciferase gene as a quantifiable tumor cell marker. Prostate 2000;44:133-43.
27. Lin JM, Lalani AS, Jooss K. Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Res 2005;65:6901-9.
28. Terranova V, Hujanen ES, Glushko V, et al. Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells. Proc Natl Acad Sci U S A 1986;83:465-9.
29. Repesh LA. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 1989;9:192-208.
30. Albini A, Iwamoto Y, McEwean RN, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239-45.
31. Samuel C, Tian H, Zhao L, Amento E. Relaxin is a key mediator of prostate growth and male reproductive tract development. Lab Invest 2003;83:1055-67.
32. Jakubczak JL, Ryan P, Hallenbeck PL, et al. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promotor, and viral replication for selectivity and efficacy. Cancer Res 2003;63:1490-9.
33. Post DE, Khuri FR, Van Meir EG, et al. Replicative oncolytic adenoviruses in multimodal cancer regimens. Hum Gene Ther 2003;14:933-46.
34. Parr MJ, Manome Y, Fine HA, et al. Tumor selective transgene expression in vivo mediated by an E2F-resposive adenoviral vector. Nat Med 1997;3:1145-9.
35. Silvertown JD, Geddes BJ, Summerlee AJS. Adenovirus-mediated expression of human prorelaxin promotes the invasive potential of canine mammary cancer cells. Endocrinology 2003;144:3683-91.
36. Liotta LA. Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. Am J Pathol 1984;117:339-48.
37. Unemori EN, Pickford LB, Amento EP, et al. Relaxin induces an extracellular matrix degradation phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest 1996;98:2739-45.
38. Netti PA, Berk DA, Jain RL, et al. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 2000;60:2497-503.
39. Pluen A, Boucher Y, Ramanujan S, et al. Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs subcutaneous tumors. Proc Natl Acad Sci U S A 2001;98:4628-33.
40. McKee T, Grandi P, Jain RK, et al. Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. Cancer Res 2006;66:2509-13.
41. Hih JY, Yuan A, Chen JW, Yang PC. Tumor-associated macrophages: its role in cancer invasion and metastasis. J Cancer Mol 2006;2:101-6.